How Effective Is Cannabis Compared to Benzodiazepines for Panic Disorder?

PostedMarch 3, 2026

UpdatedMarch 3, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Comparing cannabis vs benzodiazepines for panic disorder provides insight into treatment options for managing acute and chronic panic symptoms. Evaluating treatment comparison, efficacy, and the role of acute anxiety meds helps patients and clinicians determine the most appropriate intervention. Understanding cannabis vs benzodiazepines for panic highlights differences in onset, side effects, and long-term outcomes.

Comparing Treatment Approaches

Professional guidance is important when assessing cannabis vs benzodiazepines for panic, ensuring safe use and optimising symptom control.

Treatment Comparison

A treatment comparison reveals that benzodiazepines act quickly for acute attacks, while cannabis may offer longer-term symptom modulation.

Efficacy

Studies on efficacy indicate that cannabis can reduce panic frequency and severity for some patients, but effects are variable and depend on strain, dose, and individual response.

Acute Anxiety Meds

Acute anxiety meds like benzodiazepines provide rapid relief, whereas cannabis may be more suitable for ongoing management rather than immediate symptom interruption.

In conclusion, cannabis vs benzodiazepines for panic shows distinct advantages and limitations. Considering treatment comparison, efficacy, and acute anxiety meds help patients make informed decisions under clinical supervision.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.